GlassScriptPhysician profile
Payam Farjoodi
NPI 1841336385
$137,088.29
in general payments reported to CMS, 2019-2025
21 companies · $12K in 2025
The $12K reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,301 · 2020: $13K · 2021: $21K · 2022: $24K · 2023: $29K · 2024: $30K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $40K · Consulting Fee: $26K · Travel and Lodging: $3,480 · Food and Beverage: $1,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $39,819.45 |
| Consulting Fee | $25,550.00 |
| Travel and Lodging | $3,480.35 |
| Food and Beverage | $1,600.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Precision Spine, INC. | $75,806.83 | 2019-2025 | |
| Biogennix, LLC | $51,458.08 | 2019-2025 | Agilon Surgical Matrix, Direct Cell W/ Agilon, Directcell |
| Innovasis INC | $6,920.35 | 2022-2023 | |
| Abbott Laboratories | $502.86 | 2019-2020 | |
| Si-Bone, INC. | $463.91 | 2019-2025 | |
| Stryker Corporation | $319.62 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $218.76 | 2020-2023 | Vital, Vitality |
| Baxter Healthcare | $217.68 | 2019-2024 | Floseal |
| Corentec America INC | $204.00 | 2025 | Corentec |
| Seaspine Orthopedics Corporation | $200.12 | 2021-2022 | |
| Globus Medical, INC. | $185.13 | 2022-2023 | Evo Retrograde |
| Spineart USA INC | $156.39 | 2019 | |
| Nuvasive, INC. | $118.77 | 2020 | |
| Spineology INC. | $92.50 | 2021 | |
| Zimvie INC. | $68.26 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Highridge Medical LLC | $62.09 | 2024 | Vital |
| Lemaitre Vascular, INC. | $26.24 | 2019 | |
| Boston Scientific Corporation | $21.78 | 2019 | |
| Medtronic, INC. | $17.81 | 2022 | |
| Medtronic USA, INC. | $13.59 | 2020 | |
| Orthofix Medical, INC. | $13.52 | 2024 | Accell Evo3 C Putty |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Payam Farjoodi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.